Pathway Financial Advisers’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-91
Closed -$9.45K 465
2023
Q4
$9.45K Hold
91
﹤0.01% 366
2023
Q3
$8.86K Buy
+91
New +$9.44K ﹤0.01% 375
2023
Q1
$9.81K Hold
91
﹤0.01% 385
2022
Q4
$9.92K Buy
+91
New +$9.54K ﹤0.01% 426

Other funds holding FXH

Pathway Financial Advisers's FXH Position: Q1 2024 in Review

Pathway Financial Advisers sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q1 2024, closing a stake of 91 shares — an estimated $9.45K sold.

Pathway Financial Advisers first reported a position in FXH in Q4 2022 and held it in 4 quarters. The position peaked at $9.92K in Q4 2022. 266 funds tracked by Wall St. Rank hold FXH as of Q1 2024.

  • Pathway Financial Advisers reported no remaining First Trust Health Care AlphaDEX Fund position as of Q1 2024 after selling out during the quarter.
  • Pathway Financial Advisers sold 91 First Trust Health Care AlphaDEX Fund shares in Q1 2024, an estimated $9.45K.
  • Pathway Financial Advisers first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2022 and held it in 4 quarters.
  • Pathway Financial Advisers's First Trust Health Care AlphaDEX Fund position peaked at $9.92K in Q4 2022.
  • 266 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q1 2024.

Based on Pathway Financial Advisers's 13F filing for Q1 2024, filed 29 May 2024.